Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Homocysteine Metabolism
100%
Endothelial Function
100%
Renal Disease
100%
Microvascular Rarefaction
100%
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
100%
Disease Severity
100%
Disease Progression
100%
Homocysteine
75%
NADPH Oxidase 4 (NOX4)
52%
Endothelial Dysfunction
44%
Metabolism
30%
Nitric Oxide
30%
Microvascular Damage
22%
Early Disease
15%
Renal Failure
15%
Endothelial Injury
15%
Additional Therapy
8%
Genetic Kidney Disease
8%
Disease Identification
8%
3-point
8%
Polycystic Kidney Disease
8%
Treatment Effect
8%
Novel Biomarkers
8%
Clinical Trials
7%
Capillary
7%
Predicting Disease
7%
Progressive Enlargement
7%
Plasma Homocysteine
7%
Betaine
7%
Potential Therapy
7%
Renal Cyst
7%
Prognostic Value
7%
Preserved Renal Function
7%
Phenotypic Variability
7%
Progressive Development
7%
Medicine and Dentistry
Endothelial Function
100%
Capillary Rarefaction
100%
Disease Severity
100%
Polycystic Kidney Disease
100%
Homocysteine
100%
Nephropathy
100%
Disease Exacerbation
100%
Diseases
42%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4
40%
Endothelial Dysfunction
34%
Nitric Oxide
23%
Upregulation
17%
Biological Marker
14%
Renal Failure
14%
Reactive Oxygen Species
11%
Treatment Effect
8%
Capillary
5%
Renal Cyst
5%
Kidney Function
5%
Trimethylglycine
5%
Clinical Trial
5%
Pharmacology, Toxicology and Pharmaceutical Science
Homocysteine
75%
Capillary Rarefaction
75%
Disease Severity
75%
Kidney Disease
75%
Disease Exacerbation
75%
Kidney Polycystic Disease
75%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4
40%
Endothelial Dysfunction
34%
Nitric Oxide
23%
Diseases
17%
Clinical Trial
5%
Trimethylglycine
5%
Kidney Cyst
5%
Biological Marker
5%
Kidney Failure
5%